Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 48.63B | 46.94B | 44.81B | 42.75B | 39.54B |
Gross Profit | 4.47B | 3.80B | 4.24B | 4.20B | 4.03B |
EBITDA | 4.61B | 3.69B | 3.95B | 3.96B | 3.75B |
Net Income | 2.39B | 2.04B | 2.28B | 2.34B | 2.26B |
Balance Sheet | |||||
Total Assets | 40.08B | 39.30B | 35.81B | 31.59B | 29.78B |
Cash, Cash Equivalents and Short-Term Investments | 7.40B | 5.76B | 5.40B | 4.81B | 5.08B |
Total Debt | 9.54B | 11.18B | 7.39B | 6.45B | 6.46B |
Total Liabilities | 16.87B | 17.77B | 15.66B | 12.98B | 12.86B |
Stockholders Equity | 23.20B | 21.53B | 20.15B | 18.61B | 16.92B |
Cash Flow | |||||
Free Cash Flow | 4.02B | -2.82B | -84.00M | 271.00M | 2.73B |
Operating Cash Flow | 4.83B | 2.81B | 3.56B | 1.67B | 3.33B |
Investing Cash Flow | -729.00M | -5.54B | -3.16B | -1.28B | -444.00M |
Financing Cash Flow | -2.45B | 3.08B | 186.00M | -669.00M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥12.07B | 10.82 | 3.83% | 2.56% | 168.27% | ||
74 Outperform | ¥5.83B | 12.51 | 1.88% | 4.81% | -6.89% | ||
72 Outperform | ¥17.89B | 7.75 | 2.58% | 1.73% | -2.77% | ||
70 Outperform | ¥7.10B | 7.41 | 2.00% | 1.73% | -61.62% | ||
70 Outperform | ¥22.98B | 9.63 | 3.18% | 3.60% | 16.83% | ||
62 Neutral | ¥3.76B | 34.85 | 0.81% | 0.09% | 76.84% | ||
61 Neutral | C$6.63B | 7.56 | 3.42% | 2.77% | 6.63% | -23.02% |